Mexedia S.p.A [ALMEX] vs Compagnie Lebon [ALBON] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Mexedia S.p.A. wins in 8 metrics, Compagnie Lebon wins in 8 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Mexedia S.p.A. | Compagnie Lebon | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 8.59 | 183.93 | Mexedia S.p.A. |
| Price-to-Book Ratio | 1.23 | 0.68 | Compagnie Lebon |
| Debt-to-Equity Ratio | 0.12 | 91.01 | Mexedia S.p.A. |
| PEG Ratio | N/A | 16.12 | N/A |
| EV/EBITDA | -2.05 | 26.68 | Compagnie Lebon |
| Profit Margin (TTM) | -17.98% | 0.56% | Compagnie Lebon |
| Operating Margin (TTM) | 65.35% | 8.15% | Mexedia S.p.A. |
| EBITDA Margin (TTM) | 65.35% | 8.15% | Mexedia S.p.A. |
| Return on Equity | -49.15% | -1.86% | Compagnie Lebon |
| Return on Assets (TTM) | -12.73% | 1.22% | Compagnie Lebon |
| Free Cash Flow (TTM) | $1.57M | $5.73M | Compagnie Lebon |
| Dividend Yield | N/A | 3.44% | N/A |
| 1-Year Return | 457.60% | 8.41% | Mexedia S.p.A. |
| Price-to-Sales Ratio (TTM) | 0.38 | 1.02 | Mexedia S.p.A. |
| Enterprise Value | $48.39M | $263.89M | Compagnie Lebon |
| EV/Revenue Ratio | 0.66 | 2.31 | Mexedia S.p.A. |
| Revenue per Share (TTM) | N/A | $101 | N/A |
| Earnings per Share (Diluted) | $-2.81 | $0.56 | Compagnie Lebon |
| Beta (Stock Volatility) | -0.57 | 0.47 | Mexedia S.p.A. |
Mexedia S.p.A. vs Compagnie Lebon Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Mexedia S.p.A. | -1.85% | 2.18% | -2.09% | -34.81% | -61.10% | -50.42% |
| Compagnie Lebon | 0.41% | -12.32% | -2.77% | -1.01% | 7.91% | -1.80% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Mexedia S.p.A. | 457.60% | -79.62% | -32.98% | -32.98% | -32.98% | -32.98% |
| Compagnie Lebon | 8.41% | -0.81% | 25.96% | 25.96% | 25.96% | 25.96% |
Performance & Financial Health Analysis: Mexedia S.p.A. vs Compagnie Lebon
| Metric | ALMEX | ALBON |
|---|---|---|
| Market Information | ||
| Market Cap | €45.09M | €115.87M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 22,689 | 95 |
| 90 Day Avg. Volume | 38,555 | 227 |
| Last Close | €6.91 | €98.60 |
| 52 Week Range | €1.20 - €88.50 | €86.60 - €113.00 |
| % from 52W High | -92.19% | -12.74% |
| All-Time High | €88.50 (Aug 13, 2025) | €113.00 (May 26, 2026) |
| % from All-Time High | -92.19% | -12.74% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.60% | -0.18% |
| Quarterly Earnings Growth | N/A | 0.38% |
| Financial Health | ||
| Profit Margin (TTM) | -0.18% | 0.01% |
| Operating Margin (TTM) | 0.65% | 0.08% |
| Return on Equity (TTM) | -0.49% | -0.02% |
| Debt to Equity (MRQ) | 0.12 | 91.01 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €6.43 | €151.20 |
| Cash per Share (MRQ) | N/A | €13.46 |
| Operating Cash Flow (TTM) | €7.08M | €-8,842,000 |
| Levered Free Cash Flow (TTM) | €-20,010,000 | €-33,048,376 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 3.44% |
| Last 12-Month Dividend | N/A | €3.00 |
Valuation & Enterprise Metrics Analysis: Mexedia S.p.A. vs Compagnie Lebon
| Metric | ALMEX (Apr 24, 2026) | ALBON (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 8.59 | 183.93 |
| Forward P/E | 9.00 | 16.12 |
| PEG Ratio | N/A | 16.12 |
| Price to Sales (TTM) | 0.38 | 1.02 |
| Price to Book (MRQ) | 1.23 | 0.68 |
| Market Capitalization | ||
| Market Capitalization | €45.09M | €115.87M |
| Enterprise Value | €48.39M | €263.89M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.66 | 2.31 |
| Enterprise to EBITDA | -2.05 | 26.68 |
| Risk & Other Metrics | ||
| Beta | -0.57 | 0.47 |
| Book Value per Share (MRQ) | €6.43 | €151.20 |
Financial Statements Comparison: Mexedia S.p.A. vs Compagnie Lebon
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | ALMEX (2024) | ALBON (2024) |
|---|---|---|
| Revenue/Sales | 72.90M | 126.00M |
| Cost of Goods Sold | 65.50M | 99.04M |
| COGS % of Revenue | 89.9% | 78.6% |
| Gross Profit | 7.40M | 26.96M |
| Gross Margin | 10.2% | 21.4% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | -24.93M | 13.20M |
| Operating Margin | -34.2% | 10.5% |
| EBITDA | -23.65M | 15.29M |
| EBITDA Margin | -32.4% | 12.1% |
| Pre-Tax Income | -27.83M | -1.53M |
| Pre-Tax Income % of Revenue | -38.2% | -1.2% |
| Income Tax | -1.18M | 1.52M |
| Income Tax % of Revenue | -1.6% | 1.2% |
| Net Income (Profit) | -26.66M | -3.05M |
| Profit Margin | -36.6% | -2.4% |
Balance Sheet & Liquidity Metrics
| Metric | ALMEX (2024) | ALBON (2024) |
|---|---|---|
| Cash & Equivalents | 1.70M | 21.06M |
| Total Current Assets | 74.80M | 66.68M |
| Total Current Assets % of Revenue | 102.6% | 52.9% |
| Total Current Liabilities | 63.58M | 62.29M |
| Total Current Liabilities % of Revenue | 87.2% | 49.4% |
| Long-Term Debt | 4.67M | 116.06M |
| Long-Term Debt % of Revenue | 6.4% | 92.1% |
| Total Shareholders Equity | 40.71M | 176.22M |
| Retained Earnings | -18.58M | -149,000 |
| Retained Earnings % of Revenue | -25.5% | -0.1% |
| Property, Plant & Equipment | 214,000 | N/A |
Cash Flow Statement Comparison
| Metric | ALMEX (2024) | ALBON (2024) |
|---|---|---|
| Operating Cash Flow | 7.08M | -2.53M |
| Operating Cash Flow % of Revenue | 9.7% | -2.0% |
| Capital Expenditures | -151,000 | -12.89M |
| Free Cash Flow | 1.57M | 5.73M |
| FCF Margin | 2.2% | 4.5% |
| Debt Repayment | N/A | -21.21M |
| Common Stock Repurchase | N/A | -467,000 |
Short Interest & Institutional Ownership Analysis
| Metric | ALMEX | ALBON |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 5.69M | 1.14M |
| Float Shares | N/A | N/A |
| % Held by Insiders | 73.45% | 74.34% |
| % Held by Institutions | 0.00% | 0.62% |
| % Held by Public | 26.55% | 25.04% |
Dividend Analysis & Yield Comparison: Mexedia S.p.A. vs Compagnie Lebon
| Metric | ALMEX | ALBON |
|---|---|---|
| Last 12-Month Dividend | N/A | €3.00 |
| Last 12-Month Dividend Yield | N/A | 3.44% |
| 3-Year Avg Annual Dividend | N/A | €3.33 |
| 3-Year Avg Dividend Yield | N/A | 3.47% |
| 3-Year Total Dividends | N/A | €10.00 |
| Ex-Dividend Date | N/A | May 29, 2025 |